PDT combines a photosensitizer with a specific light source to generate reactive oxygen species and stimulate a local immune response.

Treatment usually requires multiple sessions at one- to two-week intervals, 

with follow-up HPV testing approximately three months after completion.

Some studies have reported improved HPV clearance following ALA-PDT, but results vary and it is not a guaranteed cure for HPV.

Today, we are going to talk about human papillomavirus, commonly known as HPV.

HPV can cause cervical cancer and genital warts. 

It has been reported that HPV prevalence may be as high as 34%, 

and approximately 80% of people are thought to become infected at least once during their lifetime.

When patients receive a positive HPV result, they naturally ask:

“What treatment do I need?”

Some also wonder:

“If there is no treatment, why do we get tested?”

Until recently, we often had to explain that there was no medication that directly eliminated HPV. 

Today, however, photodynamic therapy is being studied and used as a treatment option 

for persistent HPV infection and HPV-related cervical lesions.

What Is Photodynamic Therapy?

PDT stands for Photodynamic Therapy.

During the procedure, a photosensitizing agent called 5-aminolevulinic acid, or 5-ALA, is applied to the cervix. 

The treated area is then exposed to a specific light source.

This interaction generates reactive oxygen species, which may produce a local immune response, act on HPV-infected cells, promote the shedding of abnormal epithelial cells, and provide anti-inflammatory effects.

It is generally difficult to achieve the desired results with only one session.

To treat both the cervical surface and the cervical canal, the treatment areas may be alternated between sessions.

Each appointment takes approximately 30 minutes, including the application of the photosensitizing agent and exposure to the light source.

Treatment sessions are generally scheduled at intervals of one to two weeks.

Can I Return to Daily Life After Treatment?

Most patients can return to their usual daily activities immediately after the procedure.

Some may experience an increase in vaginal discharge. In rare cases, a small amount of bleeding may occur.

Photosensitizers can make treated tissue sensitive to light.

However, because the cervix is not exposed to sunlight, ordinary sunlight exposure is generally not a concern for cervical treatment.

After completing the full treatment schedule, 

patients may undergo repeat HPV testing approximately three months later to check whether the result has become negative.

Regular cervical screening remains important even if the follow-up HPV test is negative.

Is Sexual Activity Restricted During PDT?

We do not necessarily instruct every patient to abstain from sexual activity throughout the entire PDT treatment period.

PDT is intended to support the local immune response, 

so receiving treatment does not automatically mean that you cannot see your partner 

or must avoid sexual activity for the entire treatment course.

However, temporary restrictions may be recommended depending on discharge, bleeding, irritation, 

or the condition of the cervical tissue. It is best to follow the individualized instructions provided after treatment.

Can PDT Clear HPV?

Some clinical studies have reported HPV clearance following ALA-PDT, 

with rates varying according to the patient group, HPV type, cervical lesion, treatment protocol, and follow-up period.

Although a clearance rate of approximately 70% has been reported in some treatment settings, 

PDT cannot guarantee that every patient will become HPV-negative.

It may be considered a treatment option for selected patients with persistent HPV infection or HPV-related cervical lesions, particularly because there is currently no medication that directly cures the viral infection itself. 

Research has found improved HPV clearance in some patients receiving ALA-PDT, 

but the evidence and treatment protocols are still developing. 

Other Potential Uses of PDT

In addition to persistent HPV infection, PDT may be used in selected cases involving:

• Severe vaginal dryness
• Chronic vulvar itching
• Psoriasis or atopic skin conditions
• Reduced vaginal elasticity
• Recurrent vaginitis or cystitis
• Cervicitis
• Antimicrobial and regenerative care care after vaginal surgery or labiaplasty

The suitability of PDT depends on the diagnosis and the condition of the vaginal, vulvar, or cervical tissues.

Can PDT Be Used During Pregnancy?

PDT has also been studied for certain HPV-related conditions during pregnancy. 

However, evidence remains limited, and pregnancy safety cannot be guaranteed 

for every photosensitizer, device, treatment site, or clinical situation.

Pregnant patients should receive treatment only after an obstetrician has carefully evaluated its necessity, potential benefits, 

and possible risks. A small prospective study has examined ALA-PDT for genital warts during pregnancy, 

but this does not establish universal safety for treating cervical HPV or vaginitis in all pregnant patients.

Most patients experience little discomfort during treatment.

Some may notice mild pelvic aching, pressure, or an unfamiliar sensation, but this is usually temporary. 

Individual experiences can vary, so patients should inform their doctor if they experience significant pain, bleeding, or other unusual symptoms.

Managing Persistent HPV Requires Ongoing Care

PDT may provide another option for patients who feel anxious whenever HPV continues to appear on repeat testing.

However, a positive HPV result does not always require immediate treatment, 

and PDT is not a guaranteed cure. The appropriate plan should be determined according to the HPV type, 

duration of infection, cervical cytology, colposcopy findings, and presence or absence of cervical lesions.

Consistent follow-up, immune health management, and regular cervical screening remain essential for protecting your health.